The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1‐Dependent Autophagy
Biotechnology and Applied Biochemistry · 2026
DOI: 10.1002/bab.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2026. Verfasst von Yantao Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Department I (Urology Department), LONGHUA Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Beclin-1, Autophagy, Ubiquitin-Specific Proteases. Die Arbeit nennt 38 Literaturangaben. Gefördert von: General Program of National Natural Science Foundation of China, Shanghai University of Traditional Chinese Medicine Industry Development Center Medical and Nursing Integrated Science and Technology Innovation Project, The third batch of young Chinese name training program of LongHua Hospital Shanghai University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Ubiquitin‐specific peptidase 46 (USP46) is frequently underexpressed in several cancers. Its involvement and functional role in prostate cancer, however, are not well understood. This research focused on exploring how USP46 may suppress prostate cancer and its underlying mechanisms. USP46 mRNA levels in clinical prostate cancer samples were analyzed using the online The University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN) database. The expression of USP46 mRNA and protein was analyzed using RT‐PCR and immunoblotting techniques. Cell proliferation, colony formation assays, and tumor growth curves were assessed by Cell Counting Kit‐8 assay, crystal violet staining, and xenograft model, respectively. USP46's interaction with beclin 1 (BECN1) was evaluated using immunoprecipitation assays, whereas BECN1 knockdown was performed with siRNA. USP46 mRNA expression was significantly lower in prostate cancer cells compared to that in normal cells. Overexpression of USP46 significantly reduced cell proliferation, as shown by decreased cell viability and fewer colonies. Mechanistic studies demonstrated that USP46 interacted with and stabilized BECN1, supported by findings showing that USP46 overexpression increased BECN1 levels and delayed its degradation in prostate cancer cells treated with cycloheximide. Additionally, knockdown of BECN1 and inhibition of autophagy partially restored cell proliferation in USP46‐overexpressing cells. USP46 interacts with and stabilizes BECN1, promoting autophagy and thereby suppressing prostate cancer cell proliferation. In conclusion, the current findings demonstrate that USP46 abolishes cell survival of prostate cancer via enhancing BECN1‐dependent autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical Department I (Urology Department), LONGHUA Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Lei Chen
Förderung
- General Program of National Natural Science Foundation of China
- Shanghai University of Traditional Chinese Medicine Industry Development Center Medical and Nursing Integrated Science and Technology Innovation Project
- The third batch of young Chinese name training program of LongHua Hospital Shanghai University of Traditional Chinese Medicine
Zitieren
APA
Yang, Y., Cao, H., Sun, P., Feng, Y., Chen, L., & Gao, R. (2026). The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1‐Dependent Autophagy. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.70016
Vancouver
Yang Y, Cao H, Sun P, Feng Y, Chen L, Gao R. The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1‐Dependent Autophagy. Biotechnology and Applied Biochemistry. 2026. doi:10.1002/bab.70016
BibTeX
@article{Yang2026,
author = {Yang, Yantao and Cao, Hongwen and Sun, Peng and Feng, Yigeng and Chen, Lei and Gao, Renjie},
title = {The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1‐Dependent Autophagy},
journal = {Biotechnology and Applied Biochemistry},
year = {2026},
doi = {10.1002/bab.70016}
}
EUVIMED